Yash Agarwal

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Immune Response

Gold Nanoparticles

Top Venues

Nature biomedical engineering

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Khloe S Gordon, Taeyoon Kyung, Caleb R Perez, Patrick V Holec, Azucena Ramos, Angela Q Zhang, Yash Agarwal, Yunpeng Liu, Catherine E Koch, Alina Starchenko, Brian A Joughin, Douglas A Lauffenburger, Darrell J Irvine, Michael T Hemann, Michael E Birnbaum
Author Correction: Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains. Nature biomedical engineering (2023)
Kristen A Rodrigues, Christopher A Cottrell, Jon M Steichen, Bettina Groschel, Wuhbet Abraham, Heikyung Suh, Yash Agarwal, Kaiyuan Ni, Jason Y H Chang, Parisa Yousefpour, Mariane B Melo, William R Schief, Darrell J Irvine
Optimization of an alum-anchored clinical HIV vaccine candidate. NPJ vaccines 8 (1) (2023)
Khloe S Gordon, Taeyoon Kyung, Caleb R Perez, Patrick V Holec, Azucena Ramos, Angela Q Zhang, Yash Agarwal, Yunpeng Liu, Catherine E Koch, Alina Starchenko, Brian A Joughin, Douglas A Lauffenburger, Darrell J Irvine, Michael T Hemann, Michael E Birnbaum
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains. Nature biomedical engineering 6 (7) (2022)
Yash Agarwal, Lauren E Milling, Jason Y H Chang, Luciano Santollani, Allison Sheen, Emi A Lutz, Anthony Tabet, Jordan Stinson, Kaiyuan Ni, Kristen A Rodrigues, Tyson J Moyer, Mariane B Melo, Darrell J Irvine, Karl Dane Wittrup
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity. Nature biomedical engineering 6 (2) (2022)
Lauren E Milling, Daniel Garafola, Yash Agarwal, Shengwei Wu, Ayush Thomas, Nathan Donahue, Josetta Adams, Nikki Thai, Heikyung Suh, Darrell J Irvine
Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation. Cancer immunology research (2021)